Table 2 Baseline patient characteristics
Characteristic | Total | Age groups | P | ||
|---|---|---|---|---|---|
Young (18–40) | Middle-aged (40–65) | Elderly (> 65) | |||
Sample, n(%) | 464 | 60 (12.9) | 293 (63.1) | 111 (23.9) | |
Age(year), Mean ± SD | 55.0 ± 13.7 | 34.2 ± 5.4 | 52.08 ± 6.7 | 73.8 ± 5.8 | 0.000 |
BMI(kg/m2), Mean ± SD | 24.0 ± 3.7 | 24.9 ± 4.5 | 24.0 ± 3.6 | 23.5 ± 3.4 | 0.112 |
Diabetes duration(year), Mean ± SD | 7.4 ± 6.3 | 2.9 ± 3.5 | 6.5 ± 5.6 | 12.1 ± 6.5 | 0.001 |
Gender, n(%) | 0.003 | ||||
Male | 289 (62.3) | 44 (73.3) | 190 (64.8) | 55 (49.5) | |
Female | 175 (37.7) | 16 (26.7) | 103 (35.2) | 56 (50.5) | |
Education, n(%) | < 0.001 | ||||
Primary school and below | 30 (6.5) | 0 (0.0) | 10 (33.3) | 20 (66.7) | |
Junior high school | 148 (31.9) | 12 (8.1) | 102 (68.9) | 34 (23.0) | |
Senior high school | 140 (30.2) | 13 (9.3) | 92 (65.7) | 35 (25.0) | |
Junior college | 84 (18.1) | 14 (16.7) | 57 (67.9) | 13 (15.5) | |
University graduate and above | 62 (13.4) | 21 (33.9) | 32 (51.6) | 9 (14.5) | |
Complication, n (%) | 0.001 | ||||
Null | 408 (87.9) | 57 (95.0) | 267 (91.1) | 84 (75.7) | |
Cardio-cerebrovascular disease | 22 (4.7) | 1 (1.7) | 11 (3.8) | 10 (9.0) | |
Diabetic nephropathy or Peripheral neuropathy or Diabetic foot | 34 (7.3) | 2 (3.3) | 15 (5.1) | 17 (15.3) | |
Treatment plan before enrolment, n (%) | 0.003 | ||||
Oral hypoglycemic agents, | 308 (66.4) | 31 (51.7) | 197 (67.2) | 80 (72.1) | |
Oral hypoglycemic agents, and insulin | 111 (23.9) | 16 (26.7) | 68 (23.2) | 27 (24.3) | |
Others | 45 (9.7) | 13 (21.7) | 28 (9.6) | 4 (3.6) | |
FPG at baseline(mmol/L), Mean ± SD | 10.1 ± 5.0 | 10.1 ± 5.1 | 10.2 ± 5.2 | 9.8 ± 4.5 | 0.778 |
HbA1c at baseline(%), Mean ± SD | 9.9 ± 2.6 | 10.8 ± 2.6 | 10.0 ± 2.7 | 9.1 ± 2.3 | 0.055 |